Cargando…
Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response
Epithelial-to-mesenchymal transition (EMT) is linked to tumor invasion, drug resistance and aggressive disease and this is largely dependent on the cell's microenvironment. Acriflavine (ACF) is an old antibacterial drug recently also suggested as anticancer agent and HIF inhibitor. We wanted to...
Autores principales: | Dekervel, Jeroen, Bulle, Ashenafi, Windmolders, Petra, Lambrechts, Diether, Van Cutsem, Eric, Verslype, Chris, van Pelt, Jos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217771/ https://www.ncbi.nlm.nih.gov/pubmed/27987431 http://dx.doi.org/10.1016/j.tranon.2016.11.008 |
Ejemplares similares
-
Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts
por: Bulle, Ashenafi, et al.
Publicado: (2020) -
Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer
por: Bulle, Ashenafi, et al.
Publicado: (2020) -
A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular Carcinoma()
por: Dekervel, Jeroen, et al.
Publicado: (2016) -
DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
por: Galle, Eva, et al.
Publicado: (2020) -
Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality
por: van Pelt, Jos, et al.
Publicado: (2023)